Search by property

This page provides a simple browsing interface for finding entities described by a property and a named value. Other available search interfaces include the page property search, and the ask query builder.

List of results

• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 19 Paragraph 2-4  + (Article 19 Paragraph 2-4)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 19 - 20  + (Article 19 - 20)
• Reference:EU ; GBR Regulation (EC) No 178/2002 - Food Safety 01-Jul-2022 Article 2  + (Article 2)
• Reference:EU ; GBR Regulation (EC) No 1223/2009 - Cosmetic Products 01-Dec-2023 Article 2  + (Article 2)
• Reference:GBR Data Protection Act 2018 06-Jun-2022 Article 2  + (Article 2)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 2  + (Article 2)
• Reference:GBR Directive 2001/20/EC 04-Apr-2001 Article 2 (l)  + (Article 2 (l))
• Reference:GBR Directive 2001/20/EC 04-Apr-2001 Article 2 (m)  + (Article 2 (m))
• Reference:GBR Directive 2001/20/EC 04-Apr-2001 Article 2 (n)  + (Article 2 (n))
• Reference:GBR Directive 2001/20/EC 04-Apr-2001 Article 2 (o)  + (Article 2 (o))
• Reference:GBR Directive 2001/20/EC 04-Apr-2001 Article 2 (p)  + (Article 2 (p))
• Reference:EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Article 2 Paragraph 1 - 3  + (Article 2 Paragraph 1 - 3)
• Reference:EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Article 2 Paragraph 10 – 12  + (Article 2 Paragraph 10 – 12)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 2 Paragraph 13  + (Article 2 Paragraph 13)
• Reference:EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Article 2 Paragraph 14  + (Article 2 Paragraph 14)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 2 Paragraph 2 No. 32-34  + (Article 2 Paragraph 2 No. 32-34)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 2 Paragraph 26 - 29  + (Article 2 Paragraph 26 - 29)
• Reference:EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Article 2 Paragraph 4 – 8  + (Article 2 Paragraph 4 – 8)
• Reference:EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Article 2 Paragraph 45  + (Article 2 Paragraph 45)
• Reference:EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Article 2 Paragraph 46  + (Article 2 Paragraph 46)
• Reference:EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Article 2 Paragraph 62  + (Article 2 Paragraph 62)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 2 adverse event adverse reaction  + (Article 2 adverse event adverse reaction)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 2 clinical trial  + (Article 2 clinical trial)
• Reference:GBR The Medical Devices Regulations 2002 11-Feb-2021 Article 2 in vitro diagnostic medical device  + (Article 2 in vitro diagnostic medical device)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 2 investigational medicinal product  + (Article 2 investigational medicinal product)

• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 2 investigator  + (Article 2 investigator)

• Reference:GBR The Medical Devices Regulations 2002 11-Feb-2021 Article 2 medical device  + (Article 2 medical device)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 2 non-interventional trial  + (Article 2 non-interventional trial)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 2 relevant ethics committee  + (Article 2 relevant ethics committee)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 2 serious adverse event  + (Article 2 serious adverse event)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 2 unexpected adverse reaction  + (Article 2 unexpected adverse reaction)
• Reference:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 2 Paragraph 11  + (Article 2 Paragraph 11)
• Reference:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 2 Paragraph 14  + (Article 2 Paragraph 14)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 2 Paragraph 2 No. 1  + (Article 2 Paragraph 2 No. 1)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 2 Paragraph 2 No. 2  + (Article 2 Paragraph 2 No. 2)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 2 Paragraph 2 No. 3  + (Article 2 Paragraph 2 No. 3)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 2 Paragraph 2 No. 4  + (Article 2 Paragraph 2 No. 4)
• Reference:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 2 Paragraph 2 – 3  + (Article 2 Paragraph 2 – 3)
• Reference:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 2 Paragraph 4 – 6  + (Article 2 Paragraph 4 – 6)
• Reference:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 2 Paragraph 42  + (Article 2 Paragraph 42)
• Reference:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 2 Paragraph 45  + (Article 2 Paragraph 45)
• Reference:EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Article 2 Paragraph 57 – 59  + (Article 2 Paragraph 57 – 59)
• Reference:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 2 Paragraph 58  + (Article 2 Paragraph 58)
• Reference:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 2 Paragraph 60 – 62  + (Article 2 Paragraph 60 – 62)
• Reference:EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Article 2 Paragraph 64 – 66  + (Article 2 Paragraph 64 – 66)
• Reference:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 2 Paragraph 67–69  + (Article 2 Paragraph 67–69)
• Reference:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 2 Paragraph 7 – 9  + (Article 2 Paragraph 7 – 9)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 2 (1)  + (Article 2 (1))
• Reference:GBR Directive 2001/20/EC 04-Apr-2001 Article 2 (a)  + (Article 2 (a))
• Reference:GBR Directive 2001/20/EC 04-Apr-2001 Article 2 (c)  + (Article 2 (c))
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 20 Paragraph 1-3  + (Article 20 Paragraph 1-3)